Skip to content

Pacira BioSciences, Inc. PCRX Share repurchases included in accrued liabilities

Share repurchases included in accrued liabilities at other companies

IBT
IbottaIBTA
$3.6M-1.0%
HQY
HealthEquityHQY
$2.86M+42.9%
Ciena logo
CienaCIEN
$2.58M-38.6%
Ulta Beauty, Inc. logo
Ulta Beauty, Inc.ULTA
$13.75M+251%
Chipotle Mexican Grill logo
Chipotle Mexican GrillCMG
$29.19M+141%
Qualys, Inc. logo
Qualys, Inc.QLYS
$199.5K-0.5%

Other financials

Income statement

See full
Revenue$177.4M+5.0%
Gross profit$141.0M+4.7%
Operating income$6.9M+247%
Net income$2.9M-39.4%
EPS (diluted)$0.07-30.0%

Balance sheet

See full
Cash & equivalents$144.3M-49.1%
Total debt$411.2M+15.3%
Total equity$653.9M-18.1%
Total assets$1.2B-23.8%

Cash flow

See full
Operating cash flow$25.7M-27.6%
CapEx$2.7M-68.1%
Free cash flow$23.0M-14.7%

Valuation

See full
Market cap$942.78M-14.5%
Enterprise value$1.21B+2.6%
P/E183.5×
P/S1.3×-0.3×

Profitability

See full
Gross margin79.3%+1.7pp
Operating margin3.3%
Net margin0.7%
FCF margin18.1%-4.6pp

Returns & leverage

See full
Return on equity0.7%
Debt / equity0.6×+0.2×
Current ratio4.7×+2.3×

Where this comes from

Reported directly by Pacira BioSciences, Inc. in its filing.

Tagged under the XBRL concept pcrx:ShareRepurchasesNotYetPaid.

The official record: Pacira BioSciences, Inc.’s 10-K, filed February 26, 2026, on SEC EDGAR. View the filing →

Ask your AI about Pacira BioSciences, Inc.'s share repurchases included in accrued liabilities.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Pacira BioSciences, Inc.'s share repurchases included in accrued liabilities?
Pacira BioSciences, Inc. (PCRX) reported share repurchases included in accrued liabilities of $448K in Q4 2025.
What does share repurchases included in accrued liabilities mean?
Represents the value of share repurchases that have been authorized and executed but for which cash settlement has not yet occurred at the reporting date. This serves as a bridge between the total capital returned to shareholders and the actual cash outflow recorded in the period.